193 related articles for article (PubMed ID: 2699343)
1. Flow cytometry in clinical oncology: cell cycle and DNA ploidy in assessing tumor behavior.
Czerniak B; Darzynkiewicz Z; Herz F; Wersto RP; Koss LG
Mater Med Pol; 1989; 21(1):3-9. PubMed ID: 2699343
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P
Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of flow cytometry.
Raber MN
Oncology (Williston Park); 1988 Mar; 2(3):35-43, 47. PubMed ID: 3079323
[TBL] [Abstract][Full Text] [Related]
4. [Cell kinetics and nuclear ploidy pattern in relation to the growth of gastric cancers as analyzed by DNA-RNA cytofluorometry].
Kamachi M; Morotomi N; Hashimoto T; Fujimoto T; Fujiyama Y; Kagawa K; Deguchi T; Shimada N; Kodama M; Ashihara T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2342-7. PubMed ID: 6497397
[TBL] [Abstract][Full Text] [Related]
5. [DNA flow cytrometry in solid tumors].
Pinto AE; Fonseca I; Soares J
Acta Med Port; 2002; 15(2):133-42. PubMed ID: 15524158
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Morita K; Hayashi Y; Nagao S; Watanabe Y
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
[TBL] [Abstract][Full Text] [Related]
8. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
9. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma.
Ma J; Nicholas ; Terry HA; Lin SX; Patel N; Mai HG; Hong MH; Lu TX; Cui NJ; Min HQ
Ai Zheng; 2002 Jun; 21(6):644-50. PubMed ID: 12452067
[TBL] [Abstract][Full Text] [Related]
11. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
Toyota K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
[TBL] [Abstract][Full Text] [Related]
12. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
14. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B
Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry.
Huang MS; Colby TV; Therneau TM; Daly RC; Gonchoroff NJ
Cytometry; 1996 Dec; 26(4):253-9. PubMed ID: 8979023
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
19. [Cellular kinetics and the nuclear ploidy pattern in relation to the gross pathological classification and location of advanced colorectal cancers as analyzed by DNA-RNA cytofluorometry].
Hashimoto T; Morotomi N; Itoi H; Urata Y; Ueda K; Konishi E; Yagi S; Tsuchihashi Y; Kodama M; Ashihara T
Gan No Rinsho; 1990 May; 36(6):704-10. PubMed ID: 2348557
[TBL] [Abstract][Full Text] [Related]
20. Cytometry and DNA ploidy: clinical uses and molecular perspective in gastric and lung cancer.
D'Urso V; Collodoro A; Mattioli E; Giordano A; Bagella L
J Cell Physiol; 2010 Mar; 222(3):532-9. PubMed ID: 20020506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
